臭化ベクロニウム

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

臭化ベクロニウム 価格

MSDS Information

• (+)-1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide

臭化ベクロニウム 化学特性,用途語,生産方法

• 外観

  白色〜ほとんど白色, 結晶〜粉末

• 溶解性

  、エタノール(99.5)に極めて溶けやすく、うすい塩酸に溶け、水及びアセトンに溶けにくい。

• 用途

  神経筋接合部のアセチルコリ ンによる神経から筋への興奮伝達を遮断し、 D-ツボクラリンと同様非脱分極性神経遮断作 用を示します。

• 用途

  神経筋接合部のアセチルコリ ンによる神経から筋への興奮伝達を遮断し、 D- ツボクラリンと同様非脱分極性神経遮断作 用を示します。

• 効能

  骨格筋弛緩薬, 神経筋遮断薬, ムスカリン受容体拮抗薬

• 説明

  Vecuronium, 1-[(2β,3α,5α,16β,17β,)-3,17-bis(acetyloxy)-2-(1-piperidinyl) androstan-16-yl]-1-methylpiperidinium bromide (15.1.9), differs from panuronium only in the extent of alkylation. Only the piperidine substituent on C16 of the steroid skeleton is transformed into a quaternary salt.

• 化学的特性

  White Solid

• 使用

  An aminosteroid, competitive neuromuscular blocker agent.

• 定義

  ChEBI: The organic bromide salt of a 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidinino- and 16beta-N-methylpiperidinium su stituents.

• 生物学の機能

  Vecuronium bromide (Norcuron) is chemically identical to pancuronium except for a tertiary amine in place of a quaternary nitrogen. However, some of the drug will exist as the bisquaternary compound, depending on body pH. Vecuronium has a moderate onset of action (2.4 minutes) and a duration of effect of about 50 minutes. Like pancuronium, it does not block ganglia or vagal neuroeffector junctions, does not release histamine, and is eliminated by urinary excretion.

• 一般的な説明

  Vecuronium bromide, 1-(3 ,17 -dihydroxy-2 -piperidino-5 -androstan-16 -yl)-1-methylpiperidinium bromide diacetate (Norcuron), is themonoquaternary analog of pancuronium bromide. It belongsto the class of nondepolarizing neuromuscular blockingagents and produces effects similar to those of drugs in thisclass. It is unstable in the presence of acids and undergoesgradual hydrolysis of its ester functions in aqueous solution.Aqueous solutions have a pH of about 4.0.

• 作用機序

  Vecuronium bromide is a bisquaternary nitrogen compound that acts by competitively binding to nicotinic cholinergic receptors. The binding of vecuronium decreases the opportunity for acetylcholine to bind to the nicotinic receptor at the postjunctional membrane of the myoneural junction. As a result, depolarization is prevented, calcium ions are not released and muscle contraction does not occur.

• 薬理学

  Vecuronium bromide is steroidal agent that was developed in an attempt to reduce the cardiovascular effects of pancuronium. I t is similar in structure to the older drug, differing only in the loss of a methyl group from one quaternary ammonium radical. Thus it is a monoquaternary amine. An intubating dose of 0.1mgkg^-1 produces profound neuromuscular block within 3min. This dose produces clinical block for about 30min. Vecuronium rarely produces histamine release, nor does it have any direct cardiovascular effects, although it allows the cardiac effects of other anaesthetic agents, such as bradycardia produced by the opioids, to go unchallenged. Vecuronium is excreted through the kidneys (30%), although to a lesser extent than pancuronium, and undergoes hepatic deacetylation; the deacetylated metabolites have neuromuscular blocking properties. Repeated doses should be used with care in patients with renal or hepatic disease because they accumulate.

• 臨床応用

  Vecuronium Bromide is usedmainly to produce skeletal muscle relaxation during surgeryand to assist in controlled respiration after general anesthesiahas been induced.

臭化ベクロニウム 上流と下流の製品情報

臭化ベクロニウム 生産企業

Global(502)Suppliers

臭化ベクロニウム スペクトルデータ(¹HNMR、MS)

50700-72-6, 臭化ベクロニウム キーワード